BIVI icon

BioVie (BIVI)

NASDAQ

(

NaN%

)

1D
5D
1M
6M
1Y
5Y
Market open

BIVI: / ₿ NaN BTC / NaN Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$1.06 - $13.40
$10.63M
2.55
7.54M
-
Yes

What is BioVie (BIVI)?

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

The BioVie (BIVI) stock price has been falling

The BioVie Inc. Class A Common Stock (BIVI) stock price today is , reflecting a NaN% move since the market opened. The company’s market capitalization stands at $10.63M, with a daily trading volume of shares. The previous closing price was .

Get started with BioVie (BIVI)

Ready to get started? Follow the steps below, or read our guide on how to buy BioVie stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy BIVI

Search for BIVI in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy BIVI.

BIVI FAQs

BIVI is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

BIVI is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, BioVie Inc. Class A Common Stock (BIVI) has traded between a low of $1.06 and a high of $13.40.

BIVI is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in BioVie? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
BIVI icon
BIVI

Only available to USA clients through the Kraken app
or Kraken Pro.

Get the Kraken Pro app and buy BioVie in minutes

Kraken App QR Code

Explore other stocks

Most active

Explore the most-traded stocks today

TPET icon
TMDE icon
ONDS icon

ONDS

NVDA icon

NVDA

Top gainers

Browse today’s biggest stock market winners

OTRKQ icon

OTRKQ

PPBT icon
ZCMD icon

ZCMD

SVUHF icon

Top losers

Compare the worst-performing stocks of 
the day

CGBSF icon
YOTAR icon

YOTAR

OUSTZ icon

OUSTZ

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.